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1. Introduction 
The Pennsylvania Department of Health’s Diabetes Prevention and Control Program 
provided a contract to develop a Comprehensive Podogeriatric and Chronic Diseases 
Podogeriatric Assessment Protocol (Helfand Index – Appendix A). The goal was to provide 
a methodology to assess foot, ankle, and related structural problems in older patients; 
stratify those patients most at risk to develop complications; develop a surveillance 
instrument for patient care: and to serve as a public health data collection outcome 
measurement. The information obtained would also provide a protocol to develop 
prevention (primary, secondary and tertiary) and management programs for individual 
patients, institutions, and their communities, augment geriatric and chronic disease 
assessment, as well as stressing the need for appropriate patient management, professional, 
and patient education.   
Foot problems identified in older diabetic patients are the result of the aging process, 
disease, disability, deformity, and complications associated with other chronic diseases. 
They are related to societal, environmental, and life style issues. Foot discomfort and pain or 
podalgia represent some of the most distressing, disabling, and known quality of life 
limiting conditions. Diabetic foot problems in the older patient are a major cause of 
morbidity, disability, and hospitalization and contribute to a lessening of the quality and 
independence of life, thus contributing to an earlier and higher mortality. The high 
prevalence of chronic diseases in the older population, such as, diabetes mellitus, arthritis, 
peripheral arterial disease as well as those conditions that produce sensory, peripheral 
vascular, musculo-skeletal, dermatologic, onychial, and neurologic deficits, lead to serious 
complications that increase morbidity, mortality, and health care costs. (1, 2, 3, 4, 5, 6) 
Other life altering issues in the older patient include constipation, weakened muscle and 
bone structure, social isolation, mobility deficits, reduced Activities of Daily Living and 
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Instrumental Activities of Daily Living, sleep problems, agitation and compulsive disorders, 
increased perspiration, self mutilation and excoriation. The immobility that results from a 
local foot problem or as the result of a complication of a systemic disease can have a 
significant negative impact on the patient's ability to maintain a productive quality of life as 
member of society and to live life, to the end of life with dignity. The senior years should not 
become a period of “waiting for GOD”. (17, 18, 19, 20, 21) 
Diseases and disorders of foot and their related structures in the older patient and in 
particular diabetes mellitus and its neurovascular complications are a significant public 
health concern. The changes in the individuals' ability to maintain their independence 
become financial concerns for the individual, their families, and society in general. Two 
important factors involved in the older patient's ability to remain as a vital part of society 
are a keen mind and the ability to retain their mobility through ambulation. (5) 
There are many other factors, which also contribute to the development of foot problems of 
the adult population including the aging process itself as well as abuse and neglect. Some of 
these considerations include: the degree of ambulation, the duration of prior hospitalization, 
limitation of activity, prior institutionalization, episodes of social segregation, depression, 
prior care, emotional adjustments to disease and life in general, polypharmacy and drug 
interactions, and the complications and residuals associated with risk diseases. Other 
focused issues include a loss of tissue and joint elasticity; atrophy of fat and protective 
tissue; a weakening of the intrinsic muscles of the foot; a loss of balance and range of 
motion; an increase in foot size due to tissue laxity; a decrease in arch height; dry skin; and 
onychial dystrophies. (16, 18)  
High risk factors for older diabetic patients include age itself, elevated blood sugar, 
hypertension, a history of a stroke, retinopathy, nephropathy, a history and duration of 
diabetes for more than ten years, delayed treatment, failure of diabetic foot health 
education, visual impairment , the inability to bend, living alone, a history of tobacco use, 
cognitive impairment, dementia, risk taking behavior, sensory loss, a loss of protective 
sensation, structural abnormalities, altered gait, ambulatory dysfunction, abnormal or 
excessive foot pressure, subkeratotic or subungual hematoma, a history of foot ulcers, 
decreased peripheral arterial pulses, peripheral arterial and vascular disease, diabetic 
neuropathy, soft tissue and plantar fat pad atrophy and/or displacement, deformities 
(limited joint mobility, hallux valgus, hallux limitus, hammer toes, prominent metatarsal 
heads and prolapse), xerosis, fissures, obesity, and other related chronic diseases, such as 
degenerative arthritis, rheumatoid arthritis, and gout. (9, 10, 22) 
Additional systemic and/or life changes contributing to the development of high risk foot 
problems include impaired cardiovascular function, chronic constipation and incontinence, 
weakened muscle and bone structure, impaired cardiovascular function, diabetes mellitus, 
peripheral vascular and lower extremity arterial and venous disease, reduced interest 
and/or participation in social activities, decreased and/or loss of mobility, weakened 
muscle and bone structure, a reduction in independent activities of daily living and/or 
instrumental activities of daily living, sleep disorders, agitation, compulsive activities, 
increased foot perspiration, neurological and sensory deficits, neurotic excoriation, changes 
in mental status, and cognitive impairment. Self-mutilation, untreated and/or under treated 
hyperkeratosis, onychauxis, onychomycosis, ulcers, tinea pedis, xerosis, abrasions and/or 
lacerations are also contributing factors. (25, 26, 27) 
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Older patients, especially those with chronic diseases, such as diabetes mellitus are usually 
taking more than one therapeutic drug at any given moment and may have increased 
sensitivity and they are usually more susceptible to infection because of the anatomic 
location of the foot itself. Associated avascularity, atrophy of soft tissue, muscle wasting, 
neuropathic changes, and a lack of concern for foot health, is associated with the aging and 
our society. They are concerned about life, as life in a sense is a terminal illness and they 
have a lower threshold of physical and emotional stress. They may have ambulatory 
limitation and usually have one or more chronic diseases. They are more prone to injury 
involving the lower extremity that additionally limits ambulation and mobility. And, they 
are prone to present with delayed or non-healing tissues. (12) 
2. General information 
The Assessment Protocol (Appendix A) reviews information related to demographics; 
primary medical facilities and management; a history of present problems; pertinent past 
medical history; a systems review; current medications; visual evaluation, foot 
dermatologic, foot orthopedic, peripheral vascular, and neurologic evaluation; neurologic 
risk stratification; peripheral arterial risk stratification; footwear evaluation; a primary 
assessment; an initial management plan; and referral direction; Medicare's class findings; 
risk stratification of onychomycosis, plantar pressure keratotic patterns, pre and ulcer 
classification, and the classification of mechanical or pressure hyperkeratotic lesions. (22, 23, 
24) 
The evaluation process is enhanced by the use of accessible instrumentation such as a C –128 
Hz Tuning Fork; Neurologic Hammer; Percussion Hammer; Babinski Hammer; 
Neurothesiometer or similar instrumentation (Biothesiometer) to determine the Vibration 
Perception Threshold (VPT); Monofilament Sensory Testing (MST) devices such as the 
Semmes - Weinstein 5.07 nylon monofilament (SWM), Norton Monofilament, or the West 
Enhanced Sensory Test; Two Point Discriminator, Pinwheel, Tip-Therm, Tacticon; Doppler; 
Pulse Volume Recordings (PVR), Pressure-Stat, Temp-Stat, Radiometer - infrared surface 
temperature scanner for skin perfusion assessment; Ankle and Toe Brachial Index; 
Oscillometer;  Transcutaneous Oxygen (TCPO2); Radiography; MRI and CT Scans; and 
Contrast Arteriography as indicated. 
The demographics, past medical history, system review, medications and therapeutic 
programs, current health conditions should be reviewed and noted from the medical record. 
Primary foot problems as well as their relationship to chronicity and activities, including; 
swelling, pain, hyperkeratosis, joint deformities, onychial diseases and disorders, infections, 
coldness, and other problems, as well as location, quality, severity, duration, context, 
modifying factors, and associated signs and symptoms, should also be noted from the 
institutional record.  
The primary and secondary “at risk” diseases and disorders include complications 
associated with diabetes mellitus and metabolic disorders, peripheral vascular , lower 
extremity arterial and venous diseases, sensory and motor impairment, edema, degenerative 
joint changes and the residuals of arthritis and collagen diseases, ambulatory dysfunction, 
obesity, and cognitive impairment. (28) 
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In 1971, Medicare Regulations identified a number diseases and/or disorders that develop 
vascular insufficiency and neurological insensitivity and their complications as risk factors 
related to management. The primary examples include the following but are not exclusive:  
- Amyotrophic Lateral Sclerosis  
- Arteriosclerosis obliterans (A.S.O., arteriosclerosis of the extremities, occlusive 
peripheral arteriosclerosis)  
- Arteritis of the feet  
- Buerger's disease (thromboangiitis obliterans)  
- Chronic indurated cellulitis  
- Chronic thrombophlebitis  
- Chronic venous insufficiency 
- Diabetes Mellitus  
- Intractable edema - secondary to a specific disease (e.g., congestive heart failure, kidney 
disease, hypothyroidism)  
- Lymphedema - secondary to a specific disease (e.g., Milroy's disease, malignancy)  
- Peripheral neuropathies involving the feet  
Associated with malnutrition and vitamin deficiency  
- Malnutrition (general, pellagra)  
- Alcoholism  
- Malabsorption (celiac disease, tropical sprue)  
-  Pernicious anemia  
- Associated with carcinoma  
- Associated with diabetes mellitus  
- Associated with drugs and toxins  
- Associated with multiple sclerosis  
- Associated with uremia (chronic renal disease)  
- Associated with traumatic injury  
- Associated with leprosy or neurosyphilis  
- Associated with hereditary disorders  
-  Hereditary sensory radically neuropathy  
- Angiokeratoma corporis diffusum (Fabry's)  
- Amyloid neuropathy  
Peripheral vascular disease  
Raynaud's disease  
The secondary “at risk” list of diseases and disorders include the following as examples: 
Deficiency of B-complex components, Lipidoses, Amyloidosis, Peripheral autonomic 
neuropathy in disorders classified elsewhere, Hereditary and idiopathic peripheral 
neuropathy, Acute infective polyneuritis, Polyneuropathy in collagen vascular disease, 
polyneuropathy in malignant disease, Polyneuropathy in other diseases classified 
elsewhere, Alcoholic polyneuropathy, Inflammatory and toxic neuropathy, Inflammatory 
and toxic neuropathy, unspecified, Atherosclerosis of native arteries of the extremities, 
Generalized and unspecified atherosclerosis, Raynaud's syndrome, Other specified 
peripheral vascular diseases, peripheral vascular disease, unspecified, Stricture of artery, 
Other lymphedema, Postphlebitic syndrome, Compression of vein, Chronic venous 
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hypertension (idiopathic), Venous (peripheral) insufficiency, unspecified, Unspecified 
circulatory system disorder, Unspecified intestinal malabsorption, Chronic renal failure, 
Cellulitis and abscess of the toe (s), foot (feet) or leg (legs), prior foot ulceration, Hereditary 
edema of legs, Edema, and Injury to the knee, leg, ankle, and foot. 
Examples of other significant at risk diseases and disorders include as examples: old age and 
frailty, Alzheimer's Disease, Cognitive dysfunction, Osteoarthritis (Degenerative Joint 
Disease), Rheumatoid Arthritis, Gout, Coagulopathies, Hemophilia, Prior Amputation, 
Reflex Sympathetic Dystrophy, Hansen’s Disease, Mental Illness, the Mentally Challenged, 
Paralysis, Parkinson’s Disease, visual impairment, physical impairment, ambulatory 
dysfunction, . In addition, patients with a history of vascular grafts, joint implants, heart 
valve replacement, active chemotherapy, renal failure and on dialysis, anticoagulant 
therapy, hemorrhagic disease, chronic steroid therapy, and immuno – compromised states 
(HIV – AIDS), pose additional risks when considering assessment, treatment and 
prevention. (52) 
On June 16, 2009, the Department of Veterans Affairs (VHA Directive 2009-030) expanded 
the Medicare primary risk categories to appropriately include the following conditions: (50) 
- Documented peripheral arterial disease 
- Documented sensory neuropathy 
- Prior history of foot ulcer or amputation 
- Visually impaired 
- Physically impaired 
- Neuromuscular disease, i.e. Parkinson’s disease 
- Severe arthritis and spinal disc disease 
- Cognitive dysfunction 
- Chronic anticoagulation therapy 
- >70 years old without other risk factors 
- Diabetes without foot complications 
- Obesity  
3. Dermatological and onychial physical findings 
The dermatologic section provides a focus on skin integrity and multiple changes that affect 
pressure, mechanical keratosis, onychial changes, infections, and pre-ulcerative states. (7, 8, 
14) 
The primary clinical signs and findings include the following: hyperkeratosis; keratotic 
lesions without hemorrhage or hematoma; tyloma; heloma durum; heloma milliare; heloma 
molle; heloma neurofibrosuum; heloma vasculare; onychophosis; intractable plantar 
keratosis; sub-keratotic hematoma (pre-ulceration); xerosis; onychauxis; tinea pedis; 
bacterial infection; verruca; ulceration; onychomycosis; rubor; onychodystrophy; pre-
ulcerative conditions; cyanosis; and discoloration.  
Some examples of dermatologic symptoms and signs include the following: exquisitely 
painful or painless wounds, slow healing or non-healing wounds, trophic ulceration, 
necrosis, skin color changes such as cyanosis or erythema, changes in texture and turgor, 
inelasticity, tenting, pigmentation, hemosiderin deposition, pruritus, neurogenic, and/or 
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emotional dermatoses, contact dermatitis, stasis dermatitis, atopic dermatitis, nummular 
eczema, scaling, dehydration, xerosis or dryness, excoriations, verruca, moles, psoriasis, 
fissures, hyperhidrosis, bromidrosis, diminished or absent hair growth, diabetic 
dermopathy (shin spots), necrobiosis lipoidica diabeticorum, bullous diabeticorum, 
granuloma annulare, acanthosis nigricans, and poroma. Other factors include swelling, 
redness, an increase or decrease in skin temperature, and maceration.  
Some examples of common onychial clinical changes include onycholysis, subungual 
hyperkeratosis, diabetic onychopathy, onychauxis, onychogryphosis, onychocryptosis, 
onychomycosis, onychia, paronychia, subungual abscess, subungual heloma, subungual 
exostosis, onychomadesis, onychoschizia, onychophosis, subungual hematoma, splinter 
hemorrhage, periungual ulcerative granulation tissue, onychodysplasia, onychodystrophy, 
onychorrhexis, Beau's Lines, pterygium, diabetic onychopathy, and hypertrophic 
onychodystrophy.  
Onychomycosis evaluation includes: documentation of mycosis/dystrophy causing 
secondary infection and/or pain, which results or would result in marked limitation of 
ambulation and includes discoloration, hypertrophy, subungual debris, onycholysis, 
secondary infection, and limitation of ambulation and pain. The primary clinical 
presentation of onychomycosis include distal subungual, lateral subungual, superficial 
(white), proximal subungual, endonyx, total dystrophic and candida (14). The onychial 
grades at risk, which was modified and adapted from Strauss, Hart and Winant and 
recognizes earlier risk and includes the following: Grade – 1, normal; Grade – 2, mild 
hypertrophy, Grade 3, evidence of hypertrophy, dystrophy, onychauxis, onychomycosis, 
infection, and/or onychodysplasia; and Grade – 4, evidence of hypertrophy, deformity, 
onychogryphosis, dystrophy, onychomycosis, and/or infection.  
4. Hyperkeratosis classification 
The major functions of the foot are static and dynamic. The foot is an organ of      weight 
bearing, propulsion, and locomotion. The foot is relatively rigid and changes are related to 
the activities of daily living, excessive and repetitive stress, the normal aging process, 
degeneration, and disease, producing functional disability and ambulatory dysfunction. 
Repetitive stress, hard and flat surfaces, increased shock, tissue trauma, past occupational 
stress, and the environmental factors associated with ambulation that do not provide for a 
compensatory element for weight diffusion and/or weight dispersion. Examples of related 
complications include atrophy of the intrinsic foot muscles, atrophy, and anterior 
displacement of the plantar fat pad, morphologic changes, digital contractures and 
deformities, inflammation, pain, and the residuals of biomechanical, pathomechanical, and 
balance and gait change. The stress factors related to the development of hyperkeratosis 
include; force, compression, tensile stress, shearing, friction, elasticity, and fluid pressure. 
(29, 30) 
The classification of mechanical or pressure keratosis is a modification of the program 
outlined by Merriman and Tollifield , includes the following grading descriptions as 
follows: 0 - no lesion; 1 - no specific tyloma plaque but diffuse or pinch hyperkeratotic tissue 
present or in narrow bands; 2 - circumscribed, punctate oval, or circular, well defined 
thickening of keratinized tissue; 3 - heloma milliare or heloma durum with no associated 
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tyloma; 4 - well defined tyloma plaque with a definite heloma within the lesion 
extravasation, maceration and early breakdown of structures under the tyloma or callus 
layer; and 5 -complete breakdown of structure of hyperkeratotic tissue, epidermis, 
extending to superficial dermal involvement. The plantar keratoma pattern is identified if 
present. 
5. Ulcer classification 
The Ulcer Classification was adapted from Simms, Cavanaugh and Ulbrecht  and provides 
an earlier identification of risk given its ten grade classification and better identifies pre-
ulcerative changes as follows: Grade - 0 - absent skin lesions; Grade - 1 - dense callus but not 
pre-ulcer or ulcer; Grade - 2 – pre-ulcerative changes (such as evidence of hemorrhage or 
hematoma in the keratotic lesion; Grade - 3 - partial thickness (superficial ulcer); Grade - 4 - 
full thickness (deep) ulcer but no involvement of tendon, bone, ligament or joint; Grade - 5 - 
full thickness (deep) ulcer with involvement of tendon, bone, ligament or joint; Grade - 6 - 
localized infection (abscess or osteomyelitis); Grade - 7 - proximal spread of infection 
(ascending cellulitis or lymphadenopathy); Grade - 8 - gangrene of forefoot only; and Grade 
- 9 - gangrene of majority of foot. A key factor in managing the diabetic is to prevent foot 
ulceration by finding clinical signs prior to skin breakdown. (13, 41, 41, 43, 44) 
Other classifications include the Wagner Classification System (Grades 1-5) , the Liverpool 
Classification System for diabetic ulcers (Primary – neuropathic, ischemic and 
neuroischemic and Secondary – uncomplicated or complicated i.e., with cellulitis, abscess, 
or osteomyelitis, and the University of Texas Foot Ulcer Wound Classification Systems with 
Stages A, B, C, and D and Grades 1, 2, and 3 that encompass pre or post ulceration, 
superficial,   penetration to tendon or capsule or penetration to bone, with no infection or 
ischemia, infection, ischemia, and infection with and ischemia. (46)  
6. Foot orthopedic (musculoskeletal) physical findings 
The foot orthopedic section highlights altered biomechanics and the most common foot and 
joint deformities and syndromes identified in the older patient and patients with chronic 
diseases, such as arthritis; Hallux valgus (bunion); anterior imbalance (identifies 
inappropriate weight bearing and correlates with the plantar keratoma pattern noted later in 
the examination); digiti flexus (hammer toes and rotational deformities); prominent 
metatarsal heads; Morton's Syndrome; improper weight distribution and pressure areas; soft 
tissues inflammation is also noted. Other primary findings include; diminished joint 
mobility (flexion, extension, inversion, and inversion); pes planus, pes valgo planus; pes 
cavus (equinus); hallux limitus or rigidus; bursitis; Charcot joints (neuropathic arthropathy); 
drop foot; osseous reabsorption; rear and/or forefoot varus; plantarflexed first ray; digital 
and or partial foot amputation; B/K and A/K amputation; and other clinical findings. (31, 
33) 
Other examples of musculoskeletal findings that should be considered include: gradual 
change in shape or size of the foot, decreased ranges of motion, a sudden and painless 
change in foot shape with swelling and no history of trauma, drop foot, "Rocker Bottom 
Foot" or Charcot foot, neuropathic arthropathy, elevated plantar pressure, limited joint 
mobility, abnormal foot pressure, atrophy of plantar fat pad, plantar fat pad displacement, 
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foot muscle atrophy, hallux limitus, hallux rigidus, tailor’s bunion, plantar fasciitis, soft 
tissue inflammation, calcaneal spurs, decalcification, stress fractures, metatarsalgia, 
Morton's Syndrome, Haglund’s, entrapment syndrome, neuroma, sesamoid displacement, 
joint deformities as residuals of arthritis, ambulatory dysfunction, pododynia dysbasia, 
biomechanical and pathomechanical variations, and footwear evaluation. Gait evaluation 
includes mobility, gait speed, and balance as it relates to fall risk that may be associated with 
foot deformity and inappropriate footwear. Ambulatory aids such as canes, walkers, etc, as 
well as physical activities are also a consideration. Mobility should consider independent 
activity, independence with assistance, homebound status, non-ambulatory status, and 
wheel chair use. The ranges of motion include dorsiflexion, plantar flexion, inversion, and 
eversion of the foot and ankle, flexion and extension of the great toe, and intrinsic foot 
muscles. (45, 47, 48, 49) 
7. Peripheral vascular physical findings 
The Vascular Evaluation identifies those symptoms associated with arterial insufficiency 
and ischemia. The primary findings include: coldness, trophic changes, diminished or 
absent pedal pulses, such as the dorsalis pedis pulse and posterior tibial pulses; night 
cramps; edema; claudication; varicosities; atrophy and amputation if present (noted as 
above the knee (AKA), below the knee (BKA), FF (forefoot), and T (toes), which are 
particularly important in patients with diabetes and arterial insufficiency. Other findings 
include: fatigue, rest pain, decreased skin temperature, burning, trophic changes, color and 
pigmentary changes, hemosiderin deposition, petechiae, hypoxia, cyanosis, rubor, absent or 
diminished digital hair, skin fragility, skin inelasticity (tenting), tingling, numbness, 
ulceration, history of phlebitis, cramps, edema, history of repeated foot infections, 
diminished or absent popliteal and/or femoral pulse change, femoral bruits, Ankle-Brachial 
Index (ABI < 0.90), Toe-Brachial Index, prolonged subungual capillary refill (> 3 sec), 
reduced claudication time, changes in skin perfusion, color changes (rubor, erythema, or 
cyanosis), temperature changes (cool and gradient), xerosis (atrophic and dry skin), atrophy 
of soft tissue, superficial infections, onychial changes, induration, blebs, delayed venous 
filling time, prolonged capillary filling time, femoral bruits, microcirculatory dysfunction, 
ischemia, telangiectasia, stasis, delayed and/or non-healing wounds and/or ulcers, necrosis, 
and gangrene. (15, 32) 
The vascular and risk stratification includes the following as part of the initial assessment:  
0, no change; 1, mild claudication; 2, moderate claudication; 3, severe claudication; 4, 
ischemic rest pain; 5, minor tissue loss; and 6, major tissue loss. 
Medicare currently may provide payment for Therapeutic Shoes for patients with diabetes 
mellitus who meet specific criteria. The criteria include the following: a history of partial or 
complete amputation of the foot, a history of previous foot ulceration, a history of pre-
ulcerative callus, peripheral neuropathy with evidence of callus formation, evidence of foot 
and/or osseous deformity, and evidence of poor circulation.  
8. Neurological physical findings 
The neurologic evaluation identifies primary reflex and sensory changes. Those findings 
include: the deep tendon reflexes – (DTR i.e. patellar and Achilles) and superficial plantar 
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reflexes, joint position, testing vibratory sensation, vibration perception threshold (VPT), 
sharp and dull reactions, evidence of paresthesia and burning. Other findings include: 
sensory changes (burning, tingling, and/or clawing sensations), pain and hyperactivity, two 
point discrimination variation, motor changes (weakness and /or foot drop), ankle clonus, 
autonomic changes (diminished sweating or hyperhidrosis), sensory vibratory deficits 
and/or proprioceptive, loss of protective sensation, changes in pain and temperature 
perception, and high plantar pressure areas as demonstrated by marked digital contractures, 
hyperkeratosis, metatarsal prolapse, prominent metatarsal heads, and plantar fat pad 
atrophy and displacement, bowstring tendons, muscle wasting, and Charcot foot (including 
rocker bottom deformity, erythema, heat, edema, fractures, neuropathy, swelling, bounding 
pulses, absent or diminished pain and proprioception, deep tendon reflex loss, anhidrosis, 
subluxation, the minus foot, equinus, hypermobility, ulceration, hyperkeratosis, and 
infection) . The use of monofilament testing and response are essential to measure sensory 
loss. Pinching the Achilles tendon and/or placing vertical pressure on a nail plate should 
demonstrate pain. The absence of pain is also an indication of sensory loss. Palpation of the 
common peroneal, posterior tibial and sural nerves may also demonstrate enlargement and 
tenderness. (34, 35, 36, 37, 38) 
Medicare also provides a process for the evaluation and management of a diabetic patient 
with diabetic sensory neuropathy, resulting in a Loss of Protective Sensation (LOPS) to 
include the following: 1) a diagnosis of LOPS; 2) a patient history of diabetes mellitus; 3) a 
physical examination consisting of findings regarding at least the following elements, 3 a) 
visual inspection of the forefoot, hindfoot, and toe web spaces, 3 b) evaluation of protective 
sensation, 3 c) evaluation of foot structure, pathomechanics, and biomechanics, 3 d) 
evaluation of vascular status, 3 e) evaluation of skin integrity, 3 f) evaluation and 
recommendation of footwear, and 4) patient education.  
The neurological risk stratification includes the following classification: 0, no sensory loss; 1, 
sensory loss; 2, sensory loss and foot deformity; and 3, sensory loss, a history of ulceration, 
and deformity.  
9. Class findings 
Medicare also has a series of Class Findings that need to be evaluated and documented as 
qualifiers for primary foot care for those patients with primary risk diseases noted. Those 
findings include the following: A – 1, nontraumatic amputation of the foot or part of the 
foot; B – 1, absent posterior tibial pulse; B – 2, advanced trophic changes; B – 2 – a, hair 
growth (decrease or absent); B – 2 – b,  nail changes (thickening); B – 2 – c, pigmentary 
changes (discoloration);  B – 2 – d, skin texture (thin, shiny;  B – 2 – e,  skin color (rubor or 
redness); B – 3,  absent dorsalis pedis pulse; C –1,  claudication; C – 2,   temperature changes 
(cold); C – 3, edema; C – 4,  paresthesia; and  C – 5,  burning.  
10. Other findings 
Other assessment areas include footwear, hygiene, and the type of stocking (nylon, cotton, 
wool, other), or none. Stockings or socks should also be inspected for staining and excessive 
wear (friction).The shoe or footwear evaluation includes the type of shoe, fit, depth, size, 
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last, flare, shoe-wear, patterns of wear, shoe lining wear, shoe wear pattern (outsole and 
upper counter distortion), foreign bodies, insoles, and orthoses. Where special shoes, such as 
those defined as “therapeutic” by Medicare, they should generally include a padded collar 
and tongue, laces, adjustable strap or “Velcro” closure, wide toe box to accommodate 
deformities, added depth in the upper section to accommodate deformities, orthotics, and 
/or padded inserts to evenly distribute plantar pressure, a steel shank for stability, 
cushioning, and a broad sole base for support and traction.  
The  mechanical factors leading to ulceration need to be reviewed and noted, such as: body 
mass; evidence of tissue trauma; weight diffusion; weight dispersion; pathomechanics 
(defined as structural change in relation to function); biomechanics (defined as forces that 
change and affect the foot in relation to function; imbalance (defined as the inability to adapt 
to alterations of stress); force ( alteration in physical condition, either shape or position); 
compression stress ( one force moves towards another); tensile stress ( a pulling away of one 
part against another); shearing stress (a sliding of one part on the other); friction (the force 
needed to overcome resistance and usually associated with a sheering stress; elasticity ( 
weight diffusion and weight dispersion); and fluid pressure (soft tissue adaptation and 
conformity to stress).  
Given the fact that assessment and re-assessment should be completed on a regular basis, 
management can then be instituted to reduce the complications of chronic disease and 
subscribe to the principles of secondary prevention of disease. The plan for care includes the 
following, as an example: plan podiatric referral, patient education, medical referral, special 
footwear, vascular studies, clinical laboratory studies, imaging (including radiographs, 
sequential bone scans, computed tomography (CT), magnetic resonance imaging (MRI), and 
Duplex Ultrasound), prescriptions, and follow-up assessment and management. (39, 40) 
11. Discussion 
The evolution of this protocol began in 1959 as the number of older individuals and those 
with chronic diseases began to increase. Those diseases and disorders that presented with 
complications, such as diabetes mellitus, peripheral arterial disease, degenerative joint 
changes, collagen diseases, and neurosensory disorders were recognized as having a 
significant effect on the future quality of older citizens. A visit to the United Kingdom by the 
Commissioner and Deputy Commissioner of Health of the City of Philadelphia 
demonstrated a need for foot care that was a part of the British heral care system. A joint 
effort with the Philadelphia Department of Health and St. Luke’s & Children’s Medical 
Center in Philadelphia resulted in the first US Public Health Service funded program 
dealing with foot health for an aging population. “Keep Them Walking” provided a three 
years study involving information, education, screening, assessment and care for in excess 
of 16,000 citizens over the age of 65 in Philadelphia. The number of foot problems that were 
uncovered was so significant that Philadelphia established podiatric services as a part of it 
community health care program, that remain today as a vital part of providing care for older 
citizens.  
About that same time, similar efforts were initiated at the Queensbridge Health 
Maintenance Program in New York, the ambulatory clinics of the Washington, DC Health 
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Department and by the Minnesota Department of Health for Long Term Care Programs. The 
data also demonstrated a similar high prevalence for diseases and disorders of the foot and 
related structures.   
In 1963, the US Public Health Service and the Gerontological Society of America began to 
develop its first clinical geriatric practice guide that also included Podiatric programs. In 
1966, the US Department of Veterans Affairs also identified a significant need for foot care 
programs, as a part of their long term care services, especially for older adults.  It became 
clear that screening had to be replaced by Assessment, Identification, Risk Stratification, 
Education, and Treatment programs to enhance the concept of the secondary prevention of 
chronic diseases in older patients.  
The presented Clinical Podogeriatric and Chronic Disease Protocol (Helfand Index) was 
developed through a coordinated effort by the Diabetes Control Program of the 
Pennsylvania Department of Health and Temple University School of Podiatric Medicine 
and provides a means to assess older patients with diabetes mellitus and other chronic 
diseases to develop proper and appropriate care prevention and care programs.    
The most recent validation study of this protocol, Foot Problems in Older Patients – A 
Focused Podogeriatric Assessment Study in Ambulatory Care demonstrated the 
prevalence of foot conditions in older individuals and their association with chronic risk 
diseases such as diabetes mellitus, peripheral arterial disease, and arthritis, and to 
develop care plans to reduce complications from local foot problems and chronic diseases. 
One thousand individuals older than 65 years who were ambulatory and not 
institutionalized underwent a standardized and validated podogeriatric examination 
assessment protocol or index.  
The Summary of the Data is attached as Appendix B. The findings demonstrated that foot 
problems in the older population result from disease, disability, and deformity related to 
multiple chronic diseases as well as changes associated with repetitive use and trauma. 
Older people are at a high risk of developing foot-related disease and should receive 
continuing foot assessment, education, surveillance, and care. (J Am Podiatric Med Assoc 
94(3): 293-304, 2004). The data also demonstrated that 77% of all patients were deemed to be 
at risk for significant complications involving the foot and its related structures that could 
impair the quality of life and significantly increase the cost of care.  
The development of this protocol (Helfand Index) provided a means to identify older and 
diabetic patients who were at risk for complications involving the foot and its related 
structures; to focus on educational needs for patients and professionals; to provide referral 
for the rapid treatment and management of foot problems; and to provide a forum to 
discuss the need for appropriate foot wear for patients at risk, as a means to secondarily 
prevent future diseases and disorders of the foot. 
The protocol provided a focus on the current patients history, the past medical history, a 
system review, current and past medications, the assessment of skin and toe nail conditions, 
foot deformities, pathomechanical and biomechanical changes, vascular assessment, 
neurological assessment and sensory deficits, risk stratification (vascular, sensory, class 
finding, mycotic, hyperkeratotic, and ulcers), footwear and foot covering, assessment, and a 
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management plan. Examples for the reasons to refer patients for podiatric medical include 
but are not limited to the following: 
 Signs suggesting generalized diseases that include neuropathy, vascular disease, 
diabetes mellitus, infection, ulceration, deformity, degenerative joint changes, focal 
neoplastic diseases, collagen diseases, and other conditions as indicated involving the 
foot and related structures in those cases where concomitant therapy is indicated where 
initial management is not effective: 
 In the presence of skin lesions involving the foot: 
 In the presence of postural deformities of the foot and related structures: 
 In the presence of diabetes mellitus, neurosensory, peripheral vascular, and other 
risk diseases: 
 In the presence of foot problems combined with ambulatory and/or walking 
difficulty and/or a history of or risk of falls: 
 Where orthotics are indicated: 
 If the patient is unable to obtain and/or provide foot care: 
 If the patient complains of a foot problem or has specific questions about care 
including information on footwear. 
The assessment protocol clearly provided a means to identify the most significant risk 
factors. Although vascular and neurosensory deficits are usually thought of as most 
significant as to their potential impact for ulceration and amputation, class findings, 
mechanical or pressure keratosis, onychomycosis, onychial grades at risk, and pre-
ulceration, become equally important in relation to prevention and a means to provide rapid 
and early treatment for conditions noted. The protocol does provide a means to identify 
previous amputations; past foot ulcer history, peripheral neuropathy, foot deformity 
including Charcot’s Foot, peripheral vascular and arterial impairment, visual impairment, 
podalgia, pododynia dysbasia, and diabetic neuropath, especially in patient on dialysis.  All 
of these factors increase the amputation risk for diabetic patients (1, 2). In addition, the 
assessment protocol is not time consuming.  
There are a number of ulcer classifications in the literature including the Wagner 
Classification for Foot Ulcers, The University of Texas Diabetic Wound Classification, the 
National Pressure Ulcer Advisory Panel (NPUAP) Classification for Pressure Ulcers, as well 
as the one selected and described by Sims, Cavanagh, and Ulbrecht (46). This ten (10 grade 
classification provide three stages prior to a superficial ulcer that permitted earlier 
justification for treatment programs, associated with this assessment protocol.    
The Loss of Protective Sensation was initially developed by Dr. Paul Brand at the Leprosy 
Mission in London and then for the USPHS National Hansen’s Disease Program in Carville 
LA. With the recognition that the same findings were equal predictors of amputation in 
patients with diabetes mellitus, the use of the Semmes-Weinstein (5.07 gage) 10-gram 
monofilament has been defined universally in a consistent fashion to measure of light 
pressure. Vibration perception with the tuning fork 128 Hz (cps) and measurement of 
vibration perception threshold (Biothesiometer) were also employed. Pinching the Achilles 
tendon also provided a means to measure pain. Temperature perception, deep tendon 
reflexes and two-point discrimination are added procedures that provide addition al 
assessment benefits.    
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By early recognition of foot and related problems, not as an initial assessment tool, but as a 
subsequent re-assessment tool, patient education and rapid treatment program can be 
instituted to prevent progressing complications and maintain a maximum quality of 
independent life for older diabetic patients.  
Since this Protocol was introduced, it has been employed by a number of programs and 
institutions, included and identified in multiple presentations and publications. Examples 
include the following: Pennsylvania Department of Health; Pennsylvania Diabetes 
Academy; Temple University – School of Podiatric Medicine and Institute on Aging; 
University of Pennsylvania – School of Nursing; Griffin Hospital – Yale – Department of 
Veterans Affairs Health System; Geriatric Educational Resources for Residency Training 
in Family Medicine and Internal Medicine - The John A. Hartford Foundation Geriatric 
Education Consortium for Residency Training (Stanford University Geriatric Education 
Center, Baylor College of Medicine, Harvard University, Johns Hopkins University, 
Stanford University, University of California - Los Angeles, University of Chicago, 
University of Connecticut, University of Rochester, American Academy of Family 
Physicians); Pennsylvania Geriatric Education Center; Delaware Valley Geriatric 
Education Center; Thomas Jefferson University Hospital; American Medical Directors 
Association; American Podiatric Medical Association; as well as journals and texts; 
including the Geriatric Review Syllabus of the American Geriatrics Society, W B Saunders, 
Martin Dunitz, Elsevier, Wiley, McGraw-Hill, Health Professions Press, the American 
Public Health Association Press, Cambridge University Press, and Oxford University 
Press. 
12. Concluding remarks 
Much of the ability to remain ambulatory in the period of aging is directly related to foot 
health. In order to accomplish this aim, practitioners must think comprehensively, and 
recognize that team care must be an essential part of chronic disease management in the care 
of the older patient. Foot health education for patients and professionals should be 
employed. It is clear that adults with chronic diseases, such as diabetes mellitus, and older 
patients are a high risk for foot related disease and should maintain continuing foot 
assessment, education, surveillance, and care. The consequences of considering foot care for 
the older population as “routine” and a failure to prevent complications and maintain 
mobility and ambulation will result in ambulatory dysfunction, gait modification, podalgia, 
pododynia dysbasia, morbidity, mortality, increased health care costs, and will be reflected 
in the quality of life and the ability to remain mentally alert and active in their communities 
(51). For our future, the golden years must be more than aging in place, thinking of their 
residence as a waiting room, or waiting for God. We must recognize that aging is not a 
disease, that older individuals should be able to live life to the end of life with the dignity of 
age, and that we must protect what cannot be replaced. 
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14. Appendix A 
Assessment protocol   
Date Of Visit                   MR# 
Patient's Name                                  Age   
DATE OF BIRTH              SOCIAL SECURITY # 
ADDRESS 
CITY                                   STATE              ZIP CODE 
PHONE NUMBER    (    ) 
SEX           M    F                 RACE  B   W  A  L  NA 
WEIGHT     LBS                 HEIGHT     IN 
SOCIAL STATUS               M  S  W  D  SEP 
Name of primary physician/health care facility 
Date Of Last Visit 
History Of Present Illness 
SWELLING OF FEET                  LOCATION 
PAINFUL FEET                           QUALITY 
HYPERKERATOSIS                     SEVERITY 
ONYCHIAL CHANGES             DURATION 
BUNIONS                                     CONTEXT 
PAINFUL TOE NAILS                MODIFYING FACTORS 
INFECTIONS                                ASSOCIATED SIGNS & 
COLD FEET                                  SYMPTOMS 
OTHER 
Past medical history 
HEART DISEASE                          DIABETES MELLITUS 
HIGH BLOOD PRESSURE         *IDDM 
ARTHRITIS                                   *NIDDM 
*CIRCULATORY DISEASE         HYPERCHOLESTEROL 
THYROID                                      GOUT 
ALLERGY                                      FAMILY AND SOCIAL HISTORY   
                                                        SMOKING  
                                                        ALCOHOL     
System review 
CONSTITUTIONAL 
ENT                            CARD/VASC                            GU 
EYES                          MUSCULO- SKELETAL          NEUROLOGIC 
www.intechopen.com
 
A Protocol for Primary Podogeriatric Assessment for Older Patients with Diabetes Mellitus 
 
143 
SKIN/HAIR                ENDOCRINE                           GI 
RESPIRATORY        GYN                                         IMMUNOLOGIC 
PSYCHIATRIC         ALLERGIC                                  
HEMATOLOGIC      LYMPHATIC 
Medications 
Dermatologic 
*HYPERKERATOSIS                                  XEROSIS 
ONYCHAUXIS                     B-2-B             TINEA PEDIS 
INFECTION                                                 VERRUCA 
*ULCERATION                                           HEMATOMA 
ONYCHOMYCOSIS                                   RUBOR 
ONYCHODYSTROPHY                             *PREULCERATIVE 
*CYANOSIS                           B-2-E             DISCOLORED 
Foot orthopedic 
*HALLUX VALGUS                                  *HALLUX RIGIDUS-LIMITUS 
*ANTERIOR IMBALANCE                      *MORTON'S SYNDROME 
*DIGITI FLEXUS                                        BURSITIS 
*PES PLANUS                                            *PROMINENT MET HEAD 
*PES VALGOPLANUS                              *CHARCOT JOINTS 
*PES CAVUS                                               OTHER 
Vascular evaluation 
*COLDNESS                            C-2           *CLAUDICATION            C-1 
*TROPHIC CHANGES           B-2-A       VARICOSITIES 
*DP ABSENT                           B-3            OTHER 
*PT ABSENT                            B-1          *AMPUTATION 
*NIGHT CRAMPS                                  *AKA    BKA     FF    T       A-1 
*EDEMA                                  C-3           ATROPHY                        B-2-D 
Neurologic evaluation 
*ACHILLES                                               SUPERFICIAL PLANTAR 
*VIBRATORY                                           *JOINT POSITION 
*SHARP/DULL                                       *BURNING                        C-5 
*PARESTHESIA                       C-4           OTHER 
LOSS OF PROTECTIVE SENSATION 
Risk category - neurologic 
 0 = No Sensory Loss 
*1 = Sensory Loss 
*2 = Sensory Loss & Foot Deformity 
*3 = Sensory Loss, Hx Ulceration, & Deformity 
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Risk category - vascular 
 0 - 0  No Change 
*I - 1  Mild Claudication 
*I - 2  Moderate Claudication 
*I - 3  Severe Claudication 
*II - 4  Ischemic Rest Pain 
*III - 5  Minor Tissue Loss 
*III - 6  Major Tissue Loss 
Footwear Satisfactory                              Hygiene Satisfactory 
                  YES  NO                                             YES  NO 
Stockings: NYLON     COTTON     WOOL     OTHER      NONE 
                  YES  NO 
Assessment 
Plan 
Podiatric referral 
Patient education 
Medical referral 
Special footwear 
Vascular studies 
Clinical lab 
Imaging 
Rx 
Class findings 
A1      Nontraumatic Amputation 
B1       Absent Posterior Tibial 
B2       Advanced Trophic Changes 
B2A    Hair Growth (Decrease Or Absent) 
B2B     Nail Changes (Thickening) 
B2C    Pigmentary Changes (Discoloration) 
B2D    Skin Texture (Thin, Shiny) 
B2E     Skin Color (Rubor Or Redness) 
B3      Absent Dorsalis Pedis 
C1      Claudication 
C2      Temperature Changes (Cold) 
C3      Edema 
C4      Paresthesia 
C5      Burning 
Onychomycosis 
Documentation of mycosis/dystrophy causing secondary infection and/or pain that results 
or would result in marked limitation of ambulation. 
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Discoloration 
Hypertrophy 
Subungual debris 
Onycholysis 
Secondary infection 
Limitation of ambulation and pain 
Classification of mechanical or pressure hyperkeratosis 
Grade description 
0. No lesion 
1. No specific tyloma plaque, but diffuse or pinch hyperkeratotic tissue present or in 
narrow bands 
2. Circumscribed, punctate oval, or circular, well defined thickening of keratinized tissue 
3. Heloma milliare or heloma durum with no associated tyloma 
4. Well defined tyloma plaque with a definite heloma within the lesion 
5. Extravasation, maceration and early breakdown of structures under the tyloma or callus 
layer 
6. Complete breakdown of structure of hyperkeratotic tissue, epidermis, extending to 
superficial dermal involvement 
Plantar keratomata pattern 
LT 5 4 3 2 1                 RT 1 2 3 4 5 
Ulcer classification 
Grade - 0 - Absent Skin Lesions 
Grade - 1 - Dense Callus But Not Pre-Ulcer or Ulcer 
Grade - 2 - Preulcerative Changes 
Grade - 3 - Partial Thickness (Superficial Ulcer) 
Grade - 4 - Full Thickness (Deep) Ulcer But No Involvement of Tendon, Bone, Ligament  
or Joint 
Grade - 5 - Full Thickness (Deep) Ulcer With Involvement of Tendon, Bone, Ligament  
or Joint 
Grade - 6 - Localized Infection (Abscess or Osteomyelitis) 
Grade - 7 - Proximal Spread of Infection (Ascending Cellulitis or Lymphadenopathy 
Grade - 8 - Gangrene of Forefoot Only 
Grade - 9 - Gangrene of Majority of Foot 
Onychial grades at risk 
Grade I     Normal 
Grade II    Mild Hypertrophy 
Grade III   Hypertrophic 
                  Dystrophic 
                  Onychauxis 
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                   Mycotic 
                   Infected 
                   Onychodysplasia 
Grade IV    Hypertrophic 
                   Deformed 
                   Onychogryphosis 
                   Dystrophic 
                   Mycotic 
                   Infected 
15. Appendix B 
Summary of clinical findings in 1,000 older people (31) 
Patients Percentage (%) of Clinical Findings:    % 
History of present illness 
Swelling of feet       382 
Painful feet        746 
Hyperkeratosis       510 
Onychial changes       895 
Bunions        240 
Painful toenails       357 
Infections (bacterial)         37 
Cold feet        197 
Other        480 
Past history 
Heart disease       258 
High blood pressure       367 
Arthritis        421 
Circulatory disease       229 
Thyroid disease         94 
Allergy          53 
Diabetes mellitus       572 
Insulin-dependent       175 
Non-insulin-dependent      397 
Hypercholesterolemia      362 
Gout          71 
Smoking          63 
Alcohol abuse         94 
Systems review 
Constitutional         84 
Ears, nose, throat         87 
Eyes        487 
Skin/hair        642 
Respiratory        279 
Psychiatric        242 
Hematologic         21 
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Cardiac/vascular       410 
Musculoskeletal       842 
Gynecologic        420 
Lymphatic          32 
Genitourinary       273 
Neurologic        124 
Endocrine        619 
Gastrointestinal       270 
Immunologic         22 
Dermatologic evaluation 
Hyperkeratosis       770 
Onychauxis        470 
Infection          42 
Ulceration          24 
Onychomycosis       590 
Onychodystrophy       942 
Cyanosis          42 
Xerosis        652 
Tinea pedis        137 
Verruca            9 
Hematoma        104 
Rubor          61 
Preulcerative       114 
Discolored          89 
Foot orthopedic evaluation 
Hallux valgus       527 
Anterior imbalance       429 
Digiti flexus        589 
Pes planus        174 
Pes valgoplanus       121 
Pes cavus        192 
Hallux rigidus/limitus      322 
Morton’s syndrome, bursitis      107 
Prominent metatarsal head      642 
Charcot’s joint         46 
Other        172 
Vascular evaluation 
Coldness        483 
Trophic changes       796 
Dorsalis pedis pulse absent      347 
Posterior tibial pulse absent      322 
Night cramps       473 
Edema        418 
Claudication       223 
Varicosities        181 
Amputation          15 
Above-the-knee            2 
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Below-the-knee           4 
Forefoot            3 
Toes            6 
Atrophy        689 
Neurologic evaluation 
Achilles          42 
Vibratory        721 
Sharp/dull        432 
Paresthesia        684 
Superficial plantar         32 
Joint position       214 
Burning        621 
Other        384 
Risk category—neurologic 
No sensory loss       360 
Sensory loss        217 
Sensory loss and deformity      340 
Sensory loss, history of ulceration, and deformity     83 
Risk category—vascular 
No change        183 
Mild claudication       133 
Moderate claudication        90 
Severe claudication         52 
Ischemic rest pain       473 
Minor tissue loss           6 
Major tissue loss           9 
Class findings 
A-1: Nontraumatic amputation       15 
B-1: Absent posterior tibial pulse     322 
B-2: Advanced trophic changes     796 
B-2-a: Hair growth (decrease or absent)     780 
B-2-b: Nail changes (thickening)     942 
B-2-c: Pigmentary changes (discoloration)      89 
B-2-d: Skin texture (thin, shiny)     473 
B-2-e: Skin color (rubor or redness)       61 
B-3: Absent dorsalis pedis pulse     347 
C-1: Claudication       223 
C-2: Temperature changes (cold)     483 
C-3: Edema        418 
C-4: Paresthesia       684 
C-5: Burning       621 
Onychomycosis 
Discoloration       590 
Hypertrophy       590 
Subungual debris       483 
Onycholysis        521 
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Secondary infection       104 
Limitation of ambulation and pain     107 
Classification of pressure keratosis 
Grade 0: No lesion       230 
Grade 1: Diffuse or pinch        78 
Grade 2: Circumscribed oval or punctate    147 
Grade 3: Heloma milliare or durum     204 
Grade 4: Tyloma with heloma      203 
Grade 5: Extravasation or maceration     114 
Grade 6: Tissue breakdown        24 
Ulcer classification 
Grade 0: Absent skin lesions      230 
Grade 1: Dense callus      632 
Grade 2: Preulcerative changes     114 
Grade 3: Partial-thickness (superficial)       22 
Grade 4: Full-thickness (deep)          2 
Grade 5: Full-thickness (deep) with involvement  
 of tendon, bone, ligament, or joint           0 
Grade 6: Localized infection (abscess or  
 osteomyelitis)           0 
Grade 7: Proximal spread of infection (cellulitis)       0 
Grade 8: Gangrene of forefoot           0 
Grade 9: Gangrene of majority of foot         0 
Onychial grades at risk 
Grade I: Normal         58 
Grade II: Mild hypertrophy      888 
Grade III: Hypertrophy, dystrophy, onychauxis,  
 mycosis, infection, onychodysplasia    355 
Grade IV: Hypertrophy, deformity, onychogryphosis,  
 dystrophy, mycosis, infection     235 
Footwear satisfactory 
Yes         637 
No         363 
Hygiene satisfactory 
Yes         972 
No           28 
Stockings 
Nylon        587 
Cotton        302 
Wool          93 
Other          12 
None            7 
Plan 
Podiatric referral       1,000 
Medical referral       272 
Vascular studies       104 
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Imaging        123 
Patient education       1,000 
Special footwear       425 
Clinical laboratory evaluation        36 
Medication        824 
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